Treatment of Sepsis
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 57 (2), 127-132
- https://doi.org/10.2165/00003495-199957020-00001
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Confirmatory platelet-activating factor receptor antagonist trial in patients with severe Gram-negative bacterial sepsisCritical Care Medicine, 1998
- Macrophage Migration Inhibitory Factor (MIF): A Glucocorticoid Counter-Regulator within the Immune SystemCritical Reviews in Immunology, 1997
- The Inflammatory CytokinesDrugs, 1996
- Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death.Journal of Clinical Investigation, 1993
- Molecular Mapping and Detoxification of the Lipid A Binding Site by Synthetic PeptidesScience, 1993
- Lipopolysaccharide antagonistsImmunology Today, 1992
- Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in SepsisChest, 1992
- Effect of High-Dose Glucocorticoid Therapy on Mortality in Patients with Clinical Signs of Systemic SepsisNew England Journal of Medicine, 1987
- A Controlled Clinical Trial of High-Dose Methylprednisolone in the Treatment of Severe Sepsis and Septic ShockNew England Journal of Medicine, 1987
- anti-LPS factor: An anticoagulant which inhibits the endotoxin-mediated activation of coagulation systemBiochemical and Biophysical Research Communications, 1982